Skip to main navigation Skip to search Skip to main content

The evolving role of radiotherapy in early stage Hodgkin's Lymphoma

Research output: Contribution to journalReview articlepeer-review

Abstract

Radiation therapy has a key role in the combined modality treatment of early-stage Hodgkin's Lymphoma (HL). Nevertheless, late toxicity still remains an issue. A modern approach in HL radiotherapy includes lower doses and smaller fields, together with the implementation of sophisticated and dedicated delivery techniques. Aim of the present review is to discuss the current role of radiotherapy and its potential future developments, with a focus on major clinical trials, technological advances and their repercussion in the clinical management of HL patients.

Original languageEnglish
Article numbere2014035
JournalMediterranean Journal of Hematology and Infectious Diseases
Volume6
Issue number1
DOIs
Publication statusPublished - 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The evolving role of radiotherapy in early stage Hodgkin's Lymphoma'. Together they form a unique fingerprint.

Cite this